The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N03 | Antiepileptics | |
3 | N03A | Antiepileptics | |
4 | N03AE | Benzodiazepine derivatives | |
5 | N03AE01 | Clonazepam |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
Route | Amount |
---|---|
ORAL - Oral | 8 mg |
PAREN - Parenteral | 8 mg |
Active Ingredient | Description | |
---|---|---|
Clonazepam |
Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalised spike wave, spikes with temporal or other locations as well as irregular spikes and waves. |
Title | Information Source | Document Type | |
---|---|---|---|
AKLONIL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
RIVOTRIL Concentrate for solution for injection / infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
RIVOTRIL Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.